| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |